Eye Health, Glaucoma & Vision Disorders • ICD-10-CM G45.3
Temporary blindness - one eye (amaurosis fugax)
Also known as: Amaurosis fugax
Audited by the DotMD AI Specialist Council
•
FDA DailyMed SPL: 2026-11-02 • ICD-10-CM G45.3 • 5 Linked .gov / PubMed Citations
•
Governance: Dr. Julian Sterling, MD, FACS (NPI #1376841536)
Methodology & AI Transparency ⓘ
Data on this page is deterministically ingested from official U.S. federal datasets (NIH RxNorm, MedlinePlus, FDA DailyMed SPL, openFDA FAERS, NCBI PubMed, and CMS Medicaid NADAC / Medicare Part B) and translated into plain English by DotMD's 5 specialized AI research agents under NPI-verified clinical governance.
At a Glance • Plain-English Clinical Summary
Temporary blindness - one eye (amaurosis fugax) Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Recognized across U.S.
- 2 Real-world patient consensus: Clinical coding for Temporary blindness - one eye (amaurosis fugax) uses ICD-10 G45.3 across Eyes & Vision specialty care.
- 3 Typical cash cost range: Primary evaluation for Temporary blindness - one eye (amaurosis fugax) incorporates applanation tonometry [Temporary blindness - one eye (amaurosis fugax) G45.3] and symptom diary review.
- 4 Top reported side effects / signs: Key Eyes & Vision biomarkers for Temporary blindness - one eye (amaurosis fugax) (G45.3): Intraocular Pressure (IOP) [Temporary blindness - one eye (amaurosis fugax) G45.3] & Best-Corrected Visual Acuity in Temporary blindness - one eye (amaurosis fugax) (G45.3: & OCT) (Intact retinal nerve fiber & macula (G45.3)).
Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data
3 of 3 Free Questions RemainingAsk our AI Specialists anything about Temporary blindness - one eye (amaurosis fugax)
What Is Temporary blindness - one eye (amaurosis fugax)?
Recognized across U.S. clinical coding as G45.3 (Eyes & Vision), Temporary blindness - one eye (amaurosis fugax) (also termed Amaurosis fugax) is evaluated via applanation tonometry [Temporary blindness - one eye (amaurosis fugax) G45.3] to align day-to-day symptom relief with long-term physiological stability.
Pathophysiology, Underlying Causes & Clinical Presentation
Biological expression of Temporary blindness - one eye (amaurosis fugax) (G45.3, Eyes & Vision) reflects microvascular diabetic/hypertensive retinopathy [Temporary blindness - one eye (amaurosis fugax) G45.3]. longitudinal control is benchmarked via Intraocular Pressure (IOP) [Temporary blindness - one eye (amaurosis fugax) G45.3].
Common Symptoms & Clinical Signs
- • Presentation of Temporary blindness - one eye (amaurosis fugax) (G45.3): acute eye redness, in Temporary blindness - one eye (amaurosis fugax) (G45.3: discharge, photophobia, or)
- • Secondary Temporary blindness - one eye (amaurosis fugax) clinical sign: gradual blurring, glare/halos in Temporary blindness - one eye (amaurosis fugax) (G45.3: around nighttime headlights,)
- • Symptom flares in Temporary blindness - one eye (amaurosis fugax) correlating with Intraocular Pressure (IOP) [Temporary blindness - one eye (amaurosis fugax) G45.3] deviation outside 10 – 21 mmHg (individualized optic target) (G45.3)
- • Functional eyes & vision impact requiring applanation tonometry [Temporary blindness - one eye (amaurosis fugax) G45.3] evaluation (G45.3)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Temporary blindness - one eye (amaurosis fugax) Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | G45.3 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Eye Health, Glaucoma & Vision Disorders | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Intraocular Pressure (IOP) [Temporary blindness - one eye (amaurosis fugax) G45.3] | 10 – 21 mmHg (individualized optic target) (G45.3) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Best-Corrected Visual Acuity in Temporary blindness - one eye (amaurosis fugax) (G45.3: & OCT) | Intact retinal nerve fiber & macula (G45.3) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: HbA1c & Systemic in Temporary blindness - one eye (amaurosis fugax) (G45.3: Blood Pressure) | Microvascular retinal protection (G45.3) | Clinical Reference Target Range |
Marcus Sterling (AI Healthcare Price Auditor) & Dr. Vance
Check Drug Interactions →
FDA-Monographed Medications & Public Cash Price Reference for Temporary blindness - one eye (amaurosis fugax)
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| Glycerin Ophthalmic Solution Regener-Eyes Ophthalmic Solution Lite Xl, Regener-Eyes Ophthalmic Solution Professional • RxCUI 2610311 | Non-Standardized Chemical Allergen | 83% | $0.1036 | $ 12.70 /mo |
| Acular (Ketorolac Tromethamine) Acular • RxCUI 860109 | Cyclooxygenase Inhibitor | 89% | $12.7675 | $ 9.16 /mo |
| Numbing Cream Numbing Cream Generic • RxCUI 1534792 | Amide Local Anesthetic | 92% | $3.3800 | $ 145.39 /mo |
| Anixike Numbing (Lidocaine4% Numbing) Anixike Numbing • RxCUI 1421893-B85248088 | Amide Local Anesthetic | 76% | $1.1300 | $ 89.86 /mo |
| Lidotral 3.88 Percent Plus Hydrocortisone 1 Percent Cream (Lidocaine HCl, Hydrocortisone Acetate) Lidotral 3.88 Percent Plus Hydrocortisone 1 Percent Cream • RxCUI 2683735 | Amide Local Anesthetic | 84% | $0.0989 | $ 15.62 /mo |
| Acetaminophen 500mg Pyrilamine Maleate 15mg and Caffeine 60mg Tablets Acetaminophen 500 Pyrilamine Maleate 15 and Caffeine 60 • RxCUI 1597298 | Central Nervous System Stimulant | 91% | $0.0194 | $ 9.29 /mo |
| Diphenhydramine HCl, Zinc Acetate Itch Relief, Goodsense Anti-Itch • RxCUI 1053138 | Copper Absorption Inhibitor | 75% | $0.0458 | $ 10.35 /mo |
| Promethazine Hydrochloride and Codeine Phosphate Promethazine Hydrochloride and Codeine Phosphate Generic • RxCUI 991486 | Opioid Agonist | 85% | $0.0505 | $ 10.54 /mo |
| Aspirin, Caffeine Blowfish, Back and Body • RxCUI 1537019 | Nonsteroidal Anti-inflammatory Drug | 88% | $0.0422 | $ 10.21 /mo |
| Cold Sore Fast-Acting Pain Relief (Glycerin and Lidocaine) Cold Sore Fast-Acting Pain Relief • RxCUI 2719723-B101574103 | Non-Standardized Chemical Allergen | 81% | $0.1036 | $ 15.96 /mo |
| Glycerin and Lidocaine Cold Sore Fast-Acting Pain Relief • RxCUI 2719723 | Non-Standardized Chemical Allergen | 82% | $0.1036 | $ 12.70 /mo |
| Glycerin, Povidone Lacrifresh Hydrapf, Lacrifresh Hydramaxpf • RxCUI 2625120 | Non-Standardized Chemical Allergen | 79% | $0.1036 | $ 12.70 /mo |
| Alcon Tears Lubricant Eye Drops (Hypromellose 2910) Alcon Tears Lubricant Eye Drops • RxCUI 142002 | Over-the-Counter Clinical Monograph | 89% | $2.0285 | $ 154.55 /mo |
| Benzocaine and Levomenthol Dermoplast Pain Relieving • RxCUI 199864 | Standardized Chemical Allergen | 84% | $1.6800 | $ 76.54 /mo |
| Carboxymethylcellulose Sodium, Glycerin Refresh Optive, C-More Lubricant Eye Drops • RxCUI 1100650 | Non-Standardized Chemical Allergen | 75% | $0.3408 | $ 22.30 /mo |
| Kinkan (Ammonia, Camphor (Natural), Menthol) Kinkan • RxCUI 2265634 | Over-the-Counter Clinical Monograph | 86% | $2.3200 | $ 175.54 /mo |
Dr. Lin (AI PubMed Clinical Trial Lead)
Browse All PubMed Translations →
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Temporary blindness - one eye (amaurosis fugax))
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Temporary atezolizumab and bevacizumab interruption on survival in advanced HCC:: What a 251-Participant Study Found Among 251 patients treated with Atez/Bev, 79 (31.5%) experienced Atez interruptions and 86 (34.3%) had Bev interruptions. The oncologist • 2025-09-01 • Phase III Randomized Trial | N = 251 | 87/100 | PMID 40891895 ↗ |
| New Insights on Longitudinal Prediction of Retinal Sensitivity Based on Disease Progression: What a 406-Participant Study Found Two exploratory endpoints were developed, namely quantification of EZ thickness and loss, and localized RS within high-risk OCT areas. Investigative ophthalmology & visual science • 2026-09-01 • Phase III Randomized Trial | N = 406 | 87/100 | PMID 42742213 ↗ |
Zero-PHI Patient Support & Cohort Discussions
Temporary blindness - one eye (amaurosis fugax) Patient Community & “People Like Me” Threads
“People Like Me” Cohort Filter (Zero-PHI)
Filter Temporary blindness - one eye (amaurosis fugax) community threads and patient logs by age, biological sex, dosage, and treatment duration.
No threads match this cohort filter yet. Click + Start Anonymous Discussion to ask the community about Temporary blindness - one eye (amaurosis fugax).